Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
Condition: Growth Retardation Intervention: Drug: PEG-somatropin Sponsor: GeneScience Pharmaceuticals Co., Ltd. Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2017 Category: Research Source Type: clinical trials
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency Intervention: Biological: PEG-somatropin Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Beijing Children's Hospital; Tianjin Medical University General Hospital; Peking University Third Hospital; China-Japan Friendship Hospital; Dalian Children's Hospital; Xi'an Children's Hospital; Wuhan Children's Hos pital; Fuzhou Children s Hospital; Anhui Provincial Children's Hospital; Hunan Children's Hospital; Shenzhen Children's Hospital; Children's Hospital of Hebei Province; Second Affiliated Hospital of Xi...
Source: ClinicalTrials.gov - July 24, 2017 Category: Research Source Type: clinical trials
